Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frusemide Infusion for the Prevention of Deterioration of Renal Function in Post Cardiac Surgery

NCT00246675 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT00246675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00246675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frusemide Infusion for the Prevention of Deterioration of Renal Function in Post Cardiac Surgery
Lead sponsor
Melbourne Health
Phase
Not applicable
Overall status
Withdrawn
Start date
Not reported
Completion date
Not reported
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal impairment after cardiac surgery